Pulmonary Fibrosis: How Doctors Distinguish IPF from Other Causes of Lung Scarring

Pulmonary fibrosis is a condition where lung tissue becomes thickened, stiff, and scarred. This scarring makes it harder for oxygen to pass into the bloodstream, leading to breathlessness and reduced exercise capacity. Idiopathic pulmonary fibrosis (IPF) is one type of lung scarring with no known cause. However, many other conditions can lead to similar patterns of lung scarring. Distinguishing IPF from other causes is crucial for choosing the best treatment and estimating prognosis.

Understanding Pulmonary Fibrosis

Pulmonary fibrosis refers to the final common pathway of many lung injuries. Key points:

• Scar tissue replaces healthy lung tissue, reducing elasticity.
• Early symptoms include dry cough and shortness of breath with activity.
• Over time, patients may notice fatigue, weight loss, or clubbing (widening of fingertips).

When imaging or biopsies show a pattern of fibrosis, doctors must decide whether it's IPF or another form of interstitial lung disease (ILD).

Why Differentiating IPF Matters

Accurate diagnosis impacts:

• Treatment choices: Some drugs slow IPF progression but aren't effective for other ILDs.
• Prognosis: IPF generally has a more aggressive course than many other fibrosing lung diseases.
• Avoiding harmful therapies: Immunosuppressants may help connective tissue–related fibrosis but could worsen IPF.
• Clinical trials: Only patients with confirmed IPF qualify for certain trials of new therapies.

Key Steps in Diagnosis

1. Detailed Medical History

A thorough history can reveal clues that point away from IPF:

• Occupational exposures (e.g., silica, asbestos)
• Environmental exposures (e.g., bird droppings, molds)
• Medication use (e.g., certain chemotherapy drugs, amiodarone)
• Family history of lung disease
• Connective tissue disease symptoms (e.g., joint pain, skin changes, dry eyes)

2. Physical Examination

Physical findings may differ:

• IPF: Bibasilar "velcro-like" crackles on lung auscultation, finger clubbing.
• Other ILDs: Additional signs such as joint swelling, skin rash, or digital ulcers suggest connective tissue disease–associated ILD.

3. Pulmonary Function Tests (PFTs)

PFTs assess lung volumes and gas exchange:

• Restrictive pattern: Reduced total lung capacity (TLC).
• Reduced diffusion capacity for carbon monoxide (DLCO): Reflects impaired oxygen transfer.
• Serial testing: Tracking decline helps distinguish rapidly progressive IPF from more stable forms.

4. High-Resolution Computed Tomography (HRCT)

HRCT is central to diagnosis:

• IPF typical pattern (usual interstitial pneumonia, UIP):
  • Subpleural (near the lung surface) and basal (lower lung) predominance
  • Honeycombing (clusters of small cystic spaces)
  • Reticular (net-like) abnormalities
• Possible UIP or indeterminate patterns require further evaluation.
• HRCT findings that suggest non-IPF causes:
  • Upper lobe–dominant fibrosis (e.g., chronic hypersensitivity pneumonitis)
  • Nodules or ground-glass opacities in middle lung zones
  • Mosaic attenuation (patchy areas of different density) indicating air trapping

5. Blood Tests and Serology

Blood work can uncover immune-mediated causes:

• Autoantibodies: ANA, rheumatoid factor, anti–CCP, anti–Scl-70, anti–SSA/SSB
• Inflammatory markers: ESR, CRP
• Specific exposures: Hypersensitivity panels for bird antigens or mold

6. Bronchoscopy and Bronchoalveolar Lavage (BAL)

Bronchoscopy allows sampling of lung cells and fluid:

• Excludes infection: Bacteria, fungi, mycobacteria
• BAL cell counts:
  • Lymphocytosis (>20% lymphocytes) suggests hypersensitivity pneumonitis or connective tissue disease–related ILD
  • Neutrophils and eosinophils may rise in other conditions
• Fibroblast proliferation patterns can hint at UIP but are not definitive

7. Lung Biopsy

When noninvasive tests are inconclusive, tissue biopsy may be needed:

• Surgical lung biopsy (video‐assisted thoracoscopic surgery, VATS) remains the gold standard.
• Cryobiopsy (less invasive) provides adequate tissue in some centers.
• Histologic features of UIP/IPF:
  • Patchy areas of fibrosis alternating with normal lung
  • Dense collagen deposition
  • Honeycomb change
  • Fibroblast foci (areas of active scarring)
• Biopsy also rules out granulomas (hypersensitivity pneumonitis), vasculitis, or neoplastic processes.

8. Multidisciplinary Discussion

A team approach ensures accuracy:

• Pulmonologists, radiologists, pathologists, and rheumatologists review clinical, imaging, and pathology data.
• Consensus diagnosis reduces misclassification.
• Regular re-evaluation recommended as new data emerge.

Common Differential Diagnoses

Cause	Key Features
Idiopathic Pulmonary Fibrosis (IPF)	Basal/subpleural UIP pattern on HRCT; older adults; no known cause
Connective Tissue–Related ILD	Autoantibodies; joint/skin symptoms; variable imaging patterns
Chronic Hypersensitivity Pneumonitis	Exposure history; upper/mid-lung involvement; lymphocytic BAL
Drug- or Radiation-Induced Fibrosis	Medication or treatment timeline; variable imaging
Sarcoidosis	Noncaseating granulomas on biopsy; lymphadenopathy
Occupational (asbestos, silica)	Specific exposure; pleural plaques (asbestos)

Treatment Implications

Once IPF is confirmed or excluded:

• IPF therapies: Antifibrotic agents (e.g., pirfenidone, nintedanib) slow progression.
• Connective tissue–related ILD: Immunosuppressants (e.g., mycophenolate, methotrexate).
• Hypersensitivity pneumonitis: Antigen avoidance, steroids, sometimes immunosuppressants.
• Supportive care: Oxygen therapy, pulmonary rehabilitation, vaccinations.
• Lung transplant: Consider referral early for eligible patients.

Living with Pulmonary Fibrosis

• Stay active with guidance from pulmonary rehabilitation.
• Practice breathing exercises and maintain healthy weight.
• Avoid lung irritants: smoking, dust, chemical exposures.
• Monitor symptoms and lung function regularly.
• Seek support from patient groups and counselors.

Before beginning any treatment, or if you notice new or worsening symptoms, it's essential to confirm your status and discuss options with a specialist.

Could You Have Pulmonary Fibrosis?

If you've experienced persistent breathlessness, a dry cough, or decreased exercise tolerance, understanding your symptoms is an important first step toward getting the right care. Take Ubie's free AI-powered Pulmonary Fibrosis symptom checker to evaluate your symptoms in just minutes and receive personalized guidance on whether you should consult a healthcare professional.

When to Speak to a Doctor

Always consult a healthcare professional if you experience:

• Increasing shortness of breath at rest or with minimal activity
• Chest pain or discomfort
• New or worsening cough lasting more than a few weeks
• Unexplained weight loss, fatigue, or fever

Prompt medical attention ensures the best chance for early diagnosis and treatment. Pulmonary fibrosis, especially IPF, can be serious if not managed properly. Never ignore symptoms that interfere with daily life or become life-threatening.

---

This overview outlines how doctors distinguish idiopathic pulmonary fibrosis from other causes of lung scarring. Through careful history-taking, imaging, tests, and team discussion, a precise diagnosis is possible—paving the way to the most effective treatment plan.